Trends in gout and rheumatoid arthritis hospitalizations in the United States, 1993-2011

JAMA - Journal of the American Medical Association

Volumn 315, Issue 21, 2016, Pages 2345-2347

  Lim, Sian Yik ^a   Lu, Na ^a   Oza, Amar ^a   Fisher, Mark ^a   Rai, Sharan K ^b   Menendez, Mariano E ^a   Choi, Hyon K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; GOUT; HOSPITAL COST; HOSPITALIZATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREND STUDY; UNITED STATES; ADULT; AGE DISTRIBUTION; ARTHRITIS, RHEUMATOID; FACTUAL DATABASE; MIDDLE AGED; SEX RATIO; STATISTICS AND NUMERICAL DATA; TRENDS; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; FEMALE; GOUT; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; SEX DISTRIBUTION; UNITED STATES;

EID: 84973375306     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.3517     Document Type: Letter

References (6)

1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136-3141.
2. Neogi T. Clinical practice: Gout. N Engl J Med. 2011;364(5):443-452.
3. Agency for Healthcare Research and Quality. Overview of the National (Nationwide) Inpatient Sample (NIS). https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed July 8, 2015.
4. Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf. 2008;17(1):20-26.
5. Patel NJ, Deshmukh A, Pant S, et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: Implications for healthcare planning. Circulation. 2014;129(23):2371-2379.
6. Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73 (3):492-509.